The company is facing severe revenue loss from its legacy products due to generic competition, with Revlimid revenue falling by nearly $1 billion YTD. This creates immense pressure to maximize efficiency and accelerate the growth of new products, making the company receptive to solutions that improve commercial operations, pricing strategies, and market access to defend against competitors...
Filing excerpt
Revlimid revenues decreased 49% during the second quarter of 2026 and 56% year-to-date, primarily due to lower demand in the U.S. as a result of generic erosion...
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Competitors
Regions named
sec-10qcompetitorNamedGet every 10-Q signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/e9cae7ee-2e07-4d5a-8cc2-5edf538255de returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.
{
"signal_id": "e9cae7ee-2e07-4d5a-8cc2-5edf538255de",
"signal_type": "sec-10q",
"signal_subtype": "competitorNamed",
"detected_at": "2026-08-04T07:05:34.637+00:00",
"company": {
"name": "Bristol Myers Squibb",
"domain": "bms.com"
},
"data": {
"detail": "The company is facing severe revenue loss from its legacy products due to generic competition, with Revlimid revenue falling by nearly $1 billion YTD. This creates immense pressure to maximize efficiency and accelerate the growth of new products, making the company receptive to solutions that improve commercial operations, pricing strategies, and market access to defend against competitors like Dr. Reddy's Laboratories.",
"metrics": {
"pct": -0.56,
"timeframe": "current_year",
"pct_context": "Revlimid YTD revenue change",
"dollar_context": "Revlimid YTD revenue decline ($773M in 2026 vs $1,774M in 2025)",
"dollar_millions": -1001
},
"summary": "Legacy drug portfolio revenue collapses due to generic erosion; Revlimid sales down 56% YTD.",
"excerpts": "Revlimid revenues decreased 49% during the second quarter of 2026 and 56% year-to-date, primarily due to lower demand in the U.S. as a result of generic erosion...",
"relevance": 0.95,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/bmy-20260630.htm",
"filing_date": "2026-07-30",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Competitive intelligence",
"signal_category": "market",
"regions_mentioned": [
"United States",
"EU",
"Japan"
],
"vendors_mentioned": [
"Pfizer",
"Merck"
],
"competitors_mentioned": [
"Dr. Reddy's Laboratories"
]
}
}
curl https://signals.autobound.ai/v1/signals/e9cae7ee-2e07-4d5a-8cc2-5edf538255de \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bms.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.